about
Access to pain treatment as a human rightCXCR4 chemokine receptor signaling mediates pain hypersensitivity in association with antiretroviral toxic neuropathy.CRMP-2 peptide mediated decrease of high and low voltage-activated calcium channels, attenuation of nociceptor excitability, and anti-nociception in a model of AIDS therapy-induced painful peripheral neuropathyNucleic acid binding agents exert local toxic effects on neurites via a non-nuclear mechanism.African mitochondrial DNA subhaplogroups and peripheral neuropathy during antiretroviral therapyGenome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.Neurological and psychiatric adverse effects of antiretroviral drugs.Sensorimotor dysfunction in HIV/AIDS: effects of antiretroviral treatment and comorbid psychiatric disordersAlcohol consumption enhances antiretroviral painful peripheral neuropathy by mitochondrial mechanisms.Mitochondrial dysfunction in distal axons contributes to human immunodeficiency virus sensory neuropathyA modern approach to the treatment of mitochondrial diseaseRole of Drp1, a key mitochondrial fission protein, in neuropathic pain.TNFα is involved in neuropathic pain induced by nucleoside reverse transcriptase inhibitor in rats.Mitochondrial DNA D-loop AG/TC transition mutation in cortical neurons of mice after long-term exposure to nucleoside analogues.Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cellsThe cellular pharmacology of nucleoside- and nucleotide-analogue reverse-transcriptase inhibitors and its relationship to clinical toxicities.[Neuropathies related to HIV/AIDS: a clinical study in patients infected with HIV a Centre of Excellence HIV/AIDS of the University of Lubumbashi].Does mitochondrial dysfunction during antiretroviral therapy in human immunodeficiency virus infection suggest antioxidant supplementation as a beneficial option?Chemokines: integrators of pain and inflammation.HIV-1, chemokines and neurogenesis.Individualization of antiretroviral therapy.Genome-wide screen identifies drug-induced regulation of the gene giant axonal neuropathy (Gan) in a mouse model of antiretroviral-induced painful peripheral neuropathyIncreased incidence of symptomatic peripheral neuropathy among adults receiving stavudine- versus zidovudine-based antiretroviral regimens in Kenya.Wnt signaling in the pathogenesis of human HIV-associated pain syndromes.EXPRESS: Oligodendrocytes in HIV-associated pain pathogenesisThe Molecular and Pharmacological Mechanisms of HIV-Related Neuropathic Pain.Pharmacogenetics of nucleoside reverse-transcriptase inhibitor-associated peripheral neuropathyAntiretroviral treatment is associated with increased attentional load-dependent brain activation in HIV patients.A review of the toxicity of HIV medications.Antihyperalgesic Activities of Endocannabinoids in a Mouse Model of Antiretroviral-Induced Neuropathic Pain.Neuronal Stress and Injury Caused by HIV-1, cART and Drug Abuse: Converging Contributions to HAND.Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA.Pathogenesis of HIV-associated sensory neuropathy: evidence from in vivo and in vitro experimental models.Antibiotic-induced neurotoxicity.Mechanisms of distal axonal degeneration in peripheral neuropathies.Heart rate variability and heart rate turbulence in HIV-infected patients receiving combination antiretroviral therapy.Long-term exposure of mice to nucleoside analogues disrupts mitochondrial DNA maintenance in cortical neurons.Mitochondrial alterations with mitochondrial DNA depletion in the nerves of AIDS patients with peripheral neuropathy induced by 2'3'-dideoxycytidine (ddC).Fatal exacerbation of peripheral neuropathy during lamivudine therapy: evidence for iatrogenic mitochondrial damage.Effects of voluntary exercise on antiretroviral therapy-induced neuropathic pain in mice.
P2860
Q21245259-DB625DFE-3BA4-4B10-BCB8-72030A1603D1Q30480341-7E1F964C-84F1-4DD7-8B39-2103BEB2C899Q30528512-33FB4E8D-F090-40AE-AE97-9DB5CEC8AF4DQ33232600-98CED4E4-AE46-4990-BED3-AC159C7F2161Q33820470-D8F2EE7E-1E3A-4AFC-91D0-EDC603628A42Q33967087-F5DAAB54-C5F3-458F-B429-23C171101822Q34039419-29532BBB-F798-440A-9102-CCFAD6769565Q34081652-6DE03466-54AD-45E2-B4F7-ABD7814F12D4Q34283144-B06B95A0-74BD-4821-87C5-24D1BFCAC3E8Q34636367-743918D1-0967-4B75-94B7-25FFB20DC337Q35011397-3D6931C0-AD19-44B2-A982-1AFA38F3993EQ35168122-D679629D-8C00-43A9-A4B3-E169E44E8548Q35318098-76CFA7DA-0574-4078-B40D-0F9322DEE14FQ35642808-33A95DFD-EAD0-4F35-ABF3-88BDEC36AD7FQ35652741-02FF89BB-4CC9-4B68-9611-BD166CC162D5Q35676408-62550780-82B5-40B8-B599-3D4F82FD3520Q35842968-66524724-F6CC-49EB-BBEA-2FA753E611B4Q36255314-244DAF9A-1574-4730-92E4-520A8CC3F7C1Q36285939-8B50AA30-567E-4D18-BF4E-62D22CDBD6E6Q36302073-1FDC53E5-AA1F-4179-ADC4-90465A71AC40Q36441423-A63EBD14-7D0B-4D8D-8E69-FD6EE1519DA0Q36441623-08DF3E97-378E-4404-A9B2-EC90A3147CBFQ37053758-001B4994-1CB1-498C-AA73-9A22E38D3701Q37094830-315D7993-0C6F-46B5-B100-08A9B8218DEAQ37115164-A65C1641-6DF9-4528-88CC-5BBB0BEFE709Q37149019-253B7376-C778-4901-995C-2D78D2261648Q37251569-BD0EDFAC-3DAD-4575-8465-1D124558433FQ37349780-6192D730-5ABE-4B17-89B6-B58AF236952EQ37633495-443670E6-7EC6-498D-B206-24B1FC4B193FQ37710345-FB4D1208-C673-4F35-9BFE-DCEBB4120589Q37721505-724FC603-CA88-4834-B6AF-12422D08A2B2Q37798546-82FD820B-8F09-4F2D-80A3-6EE3286C5F8DQ37998517-536F954E-2774-4371-A7C6-8327004F7DA1Q38263096-A49CE2AB-E550-49F4-8F28-644977461751Q38330759-4A1ED820-FC37-4687-84CE-3D76E5D2F958Q40138186-0169067B-3E3F-48C3-95E7-81CC6F21000FQ41880290-FBF3F64B-46F6-44AA-AD48-552384454663Q43797776-A475DE0C-66CF-4E00-8B6B-84AEE563284EQ46608479-67C9E498-4940-42B0-AD6A-CCD28FFA1277Q48641734-9BCD0B03-B2F7-41AA-851F-AA6EE4D7D935
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Peripheral neuropathy and antiretroviral drugs.
@ast
Peripheral neuropathy and antiretroviral drugs.
@en
Peripheral neuropathy and antiretroviral drugs.
@nl
type
label
Peripheral neuropathy and antiretroviral drugs.
@ast
Peripheral neuropathy and antiretroviral drugs.
@en
Peripheral neuropathy and antiretroviral drugs.
@nl
prefLabel
Peripheral neuropathy and antiretroviral drugs.
@ast
Peripheral neuropathy and antiretroviral drugs.
@en
Peripheral neuropathy and antiretroviral drugs.
@nl
P1476
Peripheral neuropathy and antiretroviral drugs.
@en
P2093
Dalakas MC
P356
10.1046/J.1529-8027.2001.006001014.X
P577
2001-03-01T00:00:00Z